Outcome of patients with osteosarcoma over 40 years of age: Is angiogenesis a marker of survival?
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Surgery
Link
https://link.springer.com/content/pdf/10.1186/1477-7800-3-7.pdf
Reference28 articles.
1. Healy JH, Buss D: Radiation and Pagetic osteogenic sarcoma. Clin Orthop Relat Res. 1991, 270: 128-34.
2. Bedi HS, Kaufman DV, Choong PF, Slavin JL: Osteosarcoma of the scapular arising in osteogenesis imperfecta. Pathology. 1999, 31 (1): 52-54. 10.1080/003130299105557.
3. Carsi B, Rock MG: Primary osteosarcoma in adults older than 40 years. Clin Orthop Relat Res. 2002, 397: 53-61. 10.1097/00003086-200204000-00008.
4. Meyers PA, Heller G, Healey J, et al: Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience. J Clin Oncol. 1992, 1 (10): 5-15.
5. Link MP, Goorin AM, Miser AW, et al: The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. N Engl J Med. 1986, 314 (25): 1600-06.
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Establishment and validation of a competitive risk model for predicting cancer-specific survival in patients with osteosarcoma: a population-based study;Journal of Cancer Research and Clinical Oncology;2023-08-28
2. Doxorubicin-induced senescence in normal fibroblasts promotes in vitro tumour cell growth and invasiveness: The role of Quercetin in modulating these processes;Mechanisms of Ageing and Development;2022-09
3. Correlation of vascular endothelial growth factor with survival and pathological characteristics of patients with osteosarcoma: A systematic review and meta‐analysis;European Journal of Cancer Care;2022-06-16
4. Primary Osteosarcoma in Patients Over 75 Years of Age: A Case Series and Literature Review;In Vivo;2022
5. Primary osteosarcoma in elderly patients: A report of three cases;Oncology Letters;2019-06-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3